The Prevalence and Functional Impact of Moral Injury in Veterans
Project Number1I01RX003915-01A2
Former Number1I02RX003915-01P2
Contact PI/Project LeaderLITZ, BRETT T
Awardee OrganizationVA BOSTON HEALTH CARE SYSTEM
Description
Abstract Text
Moral Injury (MI) is the lasting psychological, biological, spiritual, behavioral, and social impact of perpetrating,
failing to prevent, bearing witness to, or being the victim of acts that transgress deeply held beliefs about right
and wrong. There is widespread acceptance of and interest in MI, but this has outpaced scientific examination.
To date, the knowledge gaps are: (1) no consensus definition of the symptoms that comprise the MI syndrome;
(2) no gold standard clinical assessment measure of MI as an outcome; (3) no definition of functionally
impairing clinically significant MI; (4) no epidemiological studies of the prevalence of different types of
potentially morally injurious events (PMIEs) and MI; (5) insufficient evidence that MI has incremental clinical
and explanatory validity; and (6) a lack of information about risk and resilience and the clinical care needs of
Veterans with MI. In this project, we have the following five aims: (1) to determine the US Veteran population
prevalence of exposure to different types of PMIEs. We have shown that different types of PMIEs are
associated with a unique constellation of problems. We hypothesize that non-perpetration based PMIEs (e.g.,
high stakes betrayal by trusted others) will be most prevalent; (2) to generate an optimally efficient threshold
severity score on the Moral Injury Outcome Scale (MIOS) that suggests probable functionally impairing MI.
Currently, there is no method that can be used by clinicians and researchers to determine the clinical
significance of MI as an outcome. This means that there is no way to distinguish moral frustration and moral
distress, which are common, from MI, a low base-rate clinical problem greatly affecting functioning, quality of
life, and potentially requiring treatment. A threshold score for caseness will help clinicians and researchers
screen and assess MI. We will use Receiver Operating Characteristic analyses, using upper quartile scores on
a quality of life and functioning measure as the criterion; (3) (primary) is to determine the prevalence of MI
cases and to explore prevalence by type of PMIE (we have no predictions about whether different types of
PMIEs will be associated with greater or lesser case prevalence). A secondary aim is to determine the
normative mean severity (and SD) of MIOS total and subscale scores and to explore these variables by type of
PMIEs (or no PMIE endorsement). We hypothesize that Veterans who endorse perpetration-based PMIEs will
have higher MIOS shame scores relative to those that endorse non-perpetration-based PMIEs, and vice versa;
(4) to examine the incremental validity of MI relative to PTSD and Depression, by testing the association
between MIOS scores and a measure of quality of life and functioning, relative to PTSD and depression. We
predict that MI symptoms will account for unique variance in functional problems; and (5) to conduct qualitative
interviews of randomly selected MI cases and matched Veterans who endorse exposure to PMIEs but low MI
symptoms and functional impact, to explore the PMIE and event context, as well as personal, professional,
and social risk and protective factors affecting outcomes after exposure to PMIEs. This exploratory aim is
designed to generate hypotheses about risk and resilience for MI and unaddressed targets for prevention and
treatment to mitigate the functional impact of MI in Veterans. We will accomplish these aims by conducting a
web survey of Veterans recruited from KnowledgePanel® (KP), a research panel of more than 50,000
households maintained by Ipsos. KP is the largest online panel that is representative of the US population.
Ipsos currently has ~5,000 Veterans in KP and has been conducting epidemiological surveys with Veterans for
20 years. Ipsos uses random probabilistic sampling methods, which means that results will be representative
of US Veterans. Sampling weights will be applied to inferential analyses to yield US Veteran population-based
estimates of exposure to different types of PMIEs for Aim 1 and the prevalence of MI as an outcome for Aim 3.
Aim 5 entails conducting qualitative interviews with MI cases and matched controls from the survey sample.
Data will be coded themes about the impact of PMIEs and strategies to repair MI will be extracted.
Public Health Relevance Statement
Moral Injury (MI) is defined as the lasting psychological, biological, spiritual, behavioral, and social impact of
perpetrating, failing to prevent, bearing witness to, or being the victim of acts that transgress deeply held moral
beliefs and expectations. Until recently, there has been no gold standard measure of MI and no information
about the extent of this problem among Veterans. This proposal entails the first national representative
epidemiological survey study of reports of exposure to potentially morally injurious events, and the extent of MI
in US Veterans. Because there is no way to define clinical cases of MI, we will use the survey results to
generate a cut-score on a new gold standard measure of MI that indicates clinically impairing levels of MI
symptoms and report the prevalence of such cases. We will also determine the clinical value of MI, relative to
PTSD and Depression, in explaining functional problems in Veterans. Finally, we will interview a random set of
MI cases and controls to examine risk and resilience and the clinical care needs of Veterans with MI.
No Sub Projects information available for 1I01RX003915-01A2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1I01RX003915-01A2
Patents
No Patents information available for 1I01RX003915-01A2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1I01RX003915-01A2
Clinical Studies
No Clinical Studies information available for 1I01RX003915-01A2
News and More
Related News Releases
No news release information available for 1I01RX003915-01A2
History
No Historical information available for 1I01RX003915-01A2
Similar Projects
No Similar Projects information available for 1I01RX003915-01A2